{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:14:46Z","timestamp":1792786486696,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MedImmune Pharmaceuticals"},{"name":"Pfizer Pharmaceuticals"},{"name":"Incyte Corporation"},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 R01 AI126915"],"award-info":[{"award-number":["5 R01 AI126915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DS Biopharma","id":[{"id":"https:\/\/ror.org\/02b082r98","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Glenmark"},{"name":"LEO Pharmaceuticals","id":[{"id":"https:\/\/ror.org\/045x7eq21","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Union Therapeutics"},{"name":"Dermira","id":[{"id":"https:\/\/ror.org\/02ac14420","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Innovaderm","id":[{"id":"https:\/\/ror.org\/0486db050","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Novan"},{"name":"Ralexar"},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly"},{"name":"Escalier"},{"DOI":"10.13039\/501100004095","name":"Kyowa Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mitsubishi Tanabe"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011831","name":"DBV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011831","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Flx Bio"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LEO Pharma","id":[{"id":"https:\/\/ror.org\/05tzrdd39","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000354","name":"Food Standards Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006423","name":"Food Allergy Research & Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006423","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MRC & Asthma UK Centre","id":[{"id":"https:\/\/ror.org\/03z7xev21","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NIHR"},{"name":"National Peanut Board","id":[{"id":"https:\/\/ror.org\/0163qa322","id-type":"ROR","asserted-by":"crossref"}]},{"name":"DBV Technologies","id":[{"id":"https:\/\/ror.org\/03cgmq069","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Astellas"},{"name":"Nestle","id":[{"id":"https:\/\/ror.org\/05aqjsn79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"BeforeBrands"},{"name":"Alladapt"},{"name":"ForTra"},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AImmune Therapeutics","id":[{"id":"https:\/\/ror.org\/00rrpnq66","id-type":"ROR","asserted-by":"crossref"}]},{"name":"DBV Technologies","id":[{"id":"https:\/\/ror.org\/03cgmq069","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["U34 AR065739-02"],"award-info":[{"award-number":["U34 AR065739-02"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DBV Technologies","id":[{"id":"https:\/\/ror.org\/03cgmq069","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Astellas"},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011831","name":"DBV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011831","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000981","name":"HAL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"NIAMS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jaci.2019.01.003","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T12:19:05Z","timestamp":1547036345000},"page":"894-913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Report from the National Institute of Allergy and Infectious Diseases workshop on \u201cAtopic dermatitis and the atopic march: Mechanisms and interventions\u201d"],"prefix":"10.1016","volume":"143","author":[{"given":"Wendy F.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Y.M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia M.","family":"Berin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal A.","family":"Chatila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raif S.","family":"Geha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Gern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi H.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Schwaninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkis","family":"Togias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.","family":"Woodfolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Plaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.01.003_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.01.003_bib2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaci.2009.11.027","article-title":"Recent insights into atopic dermatitis and implications for management of infectious complications","volume":"125","author":"Boguniewicz","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1034\/j.1398-9995.2000.00111.x","article-title":"What drives the allergic march?","volume":"55","author":"Wahn","year":"2000","journal-title":"Allergy"},{"issue":"suppl","key":"10.1016\/j.jaci.2019.01.003_bib6","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.jaci.2003.09.033","article-title":"Atopic dermatitis and the atopic march","volume":"112","author":"Spergel","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/all.12268","article-title":"Atopic dermatitis and the atopic march revisited","volume":"69","author":"Dharmage","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.01.003_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/pai.12410","article-title":"Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS","volume":"26","author":"Gough","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/pde.12867","article-title":"Study of the atopic march: development of atopic comorbidities","volume":"33","author":"Schneider","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anai.2017.10.037","article-title":"The atopic march: critical evidence and clinical relevance","volume":"120","author":"Hill","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jaci.2017.08.024","article-title":"Predicting the atopic march: results from the Canadian Healthy Infant Longitudinal Development Study","volume":"141","author":"Tran","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib12","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2011.02.041","article-title":"Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades","volume":"127","author":"Martin","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib13","series-title":"Allergy","article-title":"Eczema and contact dermatitis\u2014pathophysiology","author":"Barnetson","year":"1993"},{"key":"10.1016\/j.jaci.2019.01.003_bib14","doi-asserted-by":"crossref","first-page":"e1001748","DOI":"10.1371\/journal.pmed.1001748","article-title":"Developmental profiles of eczema, wheeze, and rhinitis: two population-based birth cohort studies","volume":"11","author":"Belgrave","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s13671-015-0121-6","article-title":"Atopic dermatitis and respiratory allergy: what is the link","volume":"4","author":"Belgrave","year":"2015","journal-title":"Curr Dermatol Rep"},{"key":"10.1016\/j.jaci.2019.01.003_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.anai.2017.10.029","article-title":"The atopic march: fact or folklore?","volume":"120","author":"Busse","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaci.2017.11.003","article-title":"Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention, and management","volume":"141","author":"Sicherer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jaci.2010.10.008","article-title":"Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report","volume":"126","author":"Boyce","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib19","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaci.2011.01.039","article-title":"Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants","volume":"127","author":"Osborne","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib20","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/j.1365-2222.2010.03567.x","article-title":"Cow's milk allergy as a predictor of bronchial hyperresponsiveness and airway inflammation at school age","volume":"40","author":"Malmberg","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.01.003_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/pai.12651","article-title":"Is there a march from early food sensitization to later childhood allergic airway disease? Results from two prospective birth cohort studies","volume":"28","author":"Alduraywish","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jaci.2017.09.034","article-title":"Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort","volume":"141","author":"du Toit","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib23","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jaci.2017.04.004","article-title":"Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march","volume":"139","author":"Czarnowicki","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2222.1998.00371.x","article-title":"Atopic dermatitis in early infancy predicts allergic airway disease at 5 years","volume":"28","author":"Bergmann","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.01.003_bib25","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1038\/ncomms9804","article-title":"Meta-analysis identifies seven susceptibility loci involved in the atopic march","volume":"6","author":"Marenholz","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2019.01.003_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2019.01.003_bib27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0091-6749(97)80009-7","article-title":"Indoor allergen exposure is a risk factor for sensitization during the first three years of life","volume":"99","author":"Wahn","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(06)69286-6","article-title":"Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study","volume":"368","author":"Illi","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2019.01.003_bib29","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaci.2012.05.053","article-title":"Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever","volume":"130","author":"Hatzler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaci.2016.08.014","article-title":"Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life","volume":"139","author":"Posa","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1183\/09031936.00163709","article-title":"Predicting persistence of wheezing: one algorithm does not fit all","volume":"35","author":"Matricardi","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2019.01.003_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1399-3038.1998.tb00305.x","article-title":"Long-lasting sensitization to food during the first two years precedes allergic airway disease. The MAS Study Group, Germany","volume":"9","author":"Kulig","year":"1998","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2007.06.041","article-title":"The prevalence of atopic triad in children with physician-confirmed atopic dermatitis","volume":"58","author":"Kapoor","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4168\/aair.2015.7.2.101","article-title":"Natural history and risk factors of atopic dermatitis in children","volume":"7","author":"Pyun","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2019.01.003_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12887-016-0673-z","article-title":"The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study","volume":"16","author":"Hill","year":"2016","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jaci.2019.01.003_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(13)70277-7","article-title":"Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study","volume":"2","author":"Pinart","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib37","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1067\/mai.2001.112943","article-title":"Childhood risk factors for atopy and the importance of early intervention","volume":"107","author":"Wahn","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a015","key":"10.1016\/j.jaci.2019.01.003_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1399-3038.13.s.15.8.x","article-title":"The childhood origins of asthma (COAST) study","author":"Lemanske","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib39","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2010.01.037","article-title":"The Urban Environment and Childhood Asthma study","volume":"125","author":"Gern","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaci.2003.11.017","article-title":"Effects of dog ownership and genotype on immune development and atopy in infancy","volume":"113","author":"Gern","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2009.11.026","article-title":"Expression patterns of atopic eczema and respiratory illnesses in a high-risk birth cohort","volume":"125","author":"Singh","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaci.2014.04.018","article-title":"Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children","volume":"134","author":"Lynch","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib43","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jaci.2017.06.040","article-title":"Early-life home environment and risk of asthma among inner-city children","volume":"141","author":"O'Connor","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/rccm.201801-0190OC","article-title":"Longitudinal phenotypes of respiratory health in a high-risk urban birth cohort","volume":"199","author":"Bacharier","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib45","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaci.2010.12.1122","article-title":"Relationships among environmental exposures, cord blood cytokine responses, allergy, and wheeze at 1 year of age in an inner-city birth cohort (Urban Environment and Childhood Asthma study)","volume":"127","author":"Wood","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaci.2016.10.052","article-title":"Patterns of immune development in urban preschoolers with recurrent wheeze and\/or atopy","volume":"140","author":"Gern","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2010.05.042","article-title":"Man's best friend? The effect of pet ownership on house dust microbial communities","volume":"126","author":"Fujimura","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib48","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1164\/rccm.201309-1700OC","article-title":"Trajectories of lung function during childhood","volume":"189","author":"Belgrave","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2008.12.014","article-title":"Household peanut consumption as a risk factor for the development of peanut allergy","volume":"123","author":"Fox","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib50","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1365-2133.2010.10068.x","article-title":"Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age","volume":"163","author":"Flohr","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib51","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaci.2014.08.011","article-title":"Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations","volume":"134","author":"Brough","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib52","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","article-title":"Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention","volume":"134","author":"Simpson","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib53","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/bjd.15747","article-title":"A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study","volume":"178","author":"Lowe","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib54","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/cea.12169","article-title":"Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis","volume":"43","author":"Wisniewski","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.01.003_bib55","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jaci.2013.08.006","article-title":"A molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease","volume":"133","author":"Romeo","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib56","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/cea.12537","article-title":"Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy","volume":"45","author":"Wisniewski","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.01.003_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam9171","article-title":"A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders","volume":"9","author":"Wambre","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib58","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jaci.2017.08.020","article-title":"TH1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status","volume":"141","author":"Wisniewski","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/infdis\/jix514","article-title":"Single-cell tracking reveals a role for pre-existing CCR5+ memory Th1 cells in the control of rhinovirus-A39 after experimental challenge in humans","volume":"217","author":"Muehling","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2019.01.003_bib60","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.01.003_bib61","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaip.2017.10.019","article-title":"Food allergy is an important risk factor for childhood asthma, irrespective of whether it resolves","volume":"6","author":"Vermeulen","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2019.01.003_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaci.2019.01.003_bib63","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaci.2014.07.060","article-title":"Application of moisturizer to neonates prevents development of atopic dermatitis","volume":"134","author":"Horimukai","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib64","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jaci.2015.08.013","article-title":"Petrolatum: barrier repair and antimicrobial responses underlying this \"inert\" moisturizer","volume":"137","author":"Czarnowicki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib65","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaci.2014.12.013","article-title":"Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year","volume":"135","author":"Kelleher","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib66","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaci.2015.12.1312","article-title":"Skin barrier impairment at birth predicts food allergy at 2 years of age","volume":"137","author":"Kelleher","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jaci.2009.07.034","article-title":"Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum","volume":"124","author":"Gao","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2012.12.668","article-title":"The multifunctional role of filaggrin in allergic skin disease","volume":"131","author":"McAleer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib69","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ng.2739","article-title":"Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting","volume":"45","author":"Samuelov","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2019.01.003_bib70","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2010.10.018","article-title":"Tight junction defects in patients with atopic dermatitis","volume":"127","author":"De Benedetto","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib71","doi-asserted-by":"crossref","first-page":"e974451","DOI":"10.4161\/21688370.2014.974451","article-title":"Epidermal tight junctions in health and disease","volume":"3","author":"Brandner","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jaci.2019.01.003_bib72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaci.2012.12.1563","article-title":"The cutaneous innate immune response in patients with atopic dermatitis","volume":"131","author":"Kuo","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib73","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2014.08.001","article-title":"Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis","volume":"134","author":"Yoshida","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib74","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/jid.2011.435","article-title":"Skin barrier disruption: a requirement for allergen sensitization?","volume":"132","author":"De Benedetto","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","article-title":"Barrier epithelial cells and the control of type 2 immunity","volume":"43","author":"Hammad","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.01.003_bib76","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9497.1","article-title":"Developing food allergy: a potential immunologic pathway linking skin barrier to gut","volume":"5","author":"Wang","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.jaci.2019.01.003_bib77","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2015.12.1306","article-title":"Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy","volume":"137","author":"Kim","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib78","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib79","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jaci.2017.10.046","article-title":"Minimally invasive skin tape strip RNA sequencing identifies novel characteristics of the type 2-high atopic dermatitis disease endotype","volume":"141","author":"Dyjack","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"3","author":"Berdyshev","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2019.01.003_bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.anai.2017.09.055","article-title":"Immunologic, microbial, and epithelial interactions in atopic dermatitis","volume":"120","author":"Brunner","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib82","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib83","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1038\/s41598-017-09207-z","article-title":"The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins","volume":"7","author":"Brunner","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2019.01.003_bib84","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/all.13223","article-title":"Nonlesional atopic dermatitis skin shares similar T-cell clones with lesional tissues","volume":"72","author":"Brunner","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2019.01.003_bib85","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Suarez-Farinas","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib86","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.jaci.2018.02.040","article-title":"Early-onset pediatric atopic dermatitis is characterized by TH2\/TH17\/TH22-centered inflammation and lipid alterations","volume":"141","author":"Brunner","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib87","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaci.2015.05.049","article-title":"Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2\/TH1 cell imbalance, whereas adults acquire CLA(+) TH22\/TC22 cell subsets","volume":"136","author":"Czarnowicki","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib88","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jaci.2016.07.013","article-title":"Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin","volume":"138","author":"Esaki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib89","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2016.04.052","article-title":"Accelerated T-cell activation and differentiation of polar subsets characterizes early atopic dermatitis development","volume":"138","author":"Esaki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib90","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jid.2016.09.037","article-title":"An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease","volume":"137","author":"Ungar","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2019.01.003_bib91","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib92","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib93","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib94","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaad.2018.01.016","article-title":"Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial","volume":"78","author":"Guttman-Yassky","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib95","doi-asserted-by":"crossref","first-page":"170ra16","DOI":"10.1126\/scitranslmed.3005374","article-title":"TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation","volume":"5","author":"Kim","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib96","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.4049\/jimmunol.1401307","article-title":"Basophils promote innate lymphoid cell responses in inflamed skin","volume":"193","author":"Kim","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib97","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1606490","article-title":"Anti-interleukin-31 receptor A\u00a0antibody for atopic dermatitis","volume":"376","author":"Ruzicka","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.01.003_bib99","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","article-title":"The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch","volume":"155","author":"Wilson","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2019.01.003_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12016-016-8548-5","article-title":"Bacterial and viral infections in atopic dermatitis: a comprehensive review","volume":"51","author":"Ong","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib101","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jaci.2019.01.003_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4651","article-title":"Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis","volume":"9","author":"Byrd","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib103","doi-asserted-by":"crossref","first-page":"16106","DOI":"10.1038\/nmicrobiol.2016.106","article-title":"Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare","volume":"1","author":"Chng","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jaci.2019.01.003_bib104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jaci.2016.07.029","article-title":"Skin microbiome before development of atopic dermatitis: early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year","volume":"139","author":"Kennedy","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib106","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bjd.14566","article-title":"Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis","volume":"175","author":"Totte","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib107","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jaci.2015.07.052","article-title":"Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis","volume":"137","author":"Tauber","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib108","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00994-16","article-title":"Clumping factor B promotes adherence of Staphylococcus aureus to corneocytes in atopic dermatitis","volume":"85","author":"Fleury","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaci.2019.01.003_bib109","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2010.09892.x","article-title":"History of eczema herpeticum is associated with the inability to induce human beta-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis","volume":"163","author":"Hata","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib110","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2010.09.015","article-title":"Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus","volume":"126","author":"Miajlovic","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1067\/mai.2001.117455","article-title":"Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin","volume":"108","author":"Cho","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib112","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jaci.2015.04.042","article-title":"Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis","volume":"136","author":"Riethmuller","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib113","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature12655","article-title":"Staphylococcus delta-toxin induces allergic skin disease by activating mast cells","volume":"503","author":"Nakamura","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2019.01.003_bib114","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaci.2012.06.019","article-title":"Staphylococcus aureus alpha-toxin modulates skin host response to viral infection","volume":"130","author":"Bin","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/CMR.00104-12","article-title":"Staphylococcal and streptococcal superantigen exotoxins","volume":"26","author":"Spaulding","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaci.2019.01.003_bib116","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaci.2010.09.002","article-title":"Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway","volume":"126","author":"Vu","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib117","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jaci.2016.01.010","article-title":"Food allergy is associated with Staphylococcus aureus colonization in children with atopic dermatitis","volume":"137","author":"Jones","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib118","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jaci.2012.10.026","article-title":"A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis","volume":"131","author":"Noval Rivas","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib119","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy","volume":"42","author":"Noval Rivas","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2019.01.003_bib120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2016.02.030","article-title":"IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function","volume":"138","author":"Noval Rivas","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib121","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/MOP.0000000000000427","article-title":"The role of the gut microbiota in food allergy","volume":"28","author":"Rachid","year":"2016","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaci.2019.01.003_bib122","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2017.02.007","article-title":"The microbiome in allergic disease: current understanding and future opportunities\u20142017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology","volume":"139","author":"Huang","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib123","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa013536","article-title":"Avon Longitudinal Study of Parents and Children Study Team. Factors associated with the development of peanut allergy in childhood","volume":"348","author":"Lack","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2019.01.003_bib124","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaci.2014.10.007","article-title":"Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy","volume":"135","author":"Brough","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib125","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nri.2017.39","article-title":"Early life factors that affect allergy development","volume":"17","author":"Reynolds","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib126","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cea.13111","article-title":"Environmental peanut exposure increases the risk of peanut sensitization in high-risk children","volume":"48","author":"Brough","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2019.01.003_bib127","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaci.2012.11.032","article-title":"Epicutaneous sensitization results in IgE-dependent intestinal mast cell expansion and food-induced anaphylaxis","volume":"131","author":"Bartnikas","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imr.12546","article-title":"The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines","volume":"278","author":"Han","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2019.01.003_bib129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2013.12.1045","article-title":"Food allergy: insights into etiology, prevention, and treatment provided by murine models","volume":"133","author":"Oyoshi","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2015.12.1304","article-title":"Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis","volume":"138","author":"Oyoshi","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib131","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.4049\/jimmunol.1201677","article-title":"Cutting edge: allergen-specific CD4 T cells respond indirectly to thymic stromal lymphopoietin to promote allergic responses in the skin","volume":"190","author":"Larson","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib132","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1172\/JCI77798","article-title":"Thymic stromal lymphopoietin-mediated epicutaneous inflammation promotes acute diarrhea and anaphylaxis","volume":"124","author":"Han","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.01.003_bib133","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41598-017-01863-5","article-title":"Intradermal administration of IL-33 induces allergic airway inflammation","volume":"7","author":"Han","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2019.01.003_bib134","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaci.2016.03.056","article-title":"IL-33 promotes food anaphylaxis in epicutaneously sensitized mice by targeting mast cells","volume":"138","author":"Galand","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib135","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors","volume":"132","author":"Savinko","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2019.01.003_bib136","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1172\/JCI75660","article-title":"Skin exposure promotes a Th2-dependent sensitization to peanut allergens","volume":"124","author":"Tordesillas","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2019.01.003_bib137","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jaci.2014.01.022","article-title":"Atopic phenotypes identified with latent class analyses at age 2 years","volume":"134","author":"Havstad","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib138","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaci.2016.03.057","article-title":"Epicutaneous immunotherapy induces gastrointestinal LAP(+) regulatory T cells and prevents food-induced anaphylaxis","volume":"139","author":"Tordesillas","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.01.003_bib139","article-title":"Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell-related immunity and angiogenesis","author":"McAleer","year":"2018","journal-title":"Br J Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919300144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674919300144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:18:50Z","timestamp":1758791930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674919300144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0091674919300144"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.01.003","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Report from the National Institute of Allergy and Infectious Diseases workshop on \u201cAtopic dermatitis and the atopic march: Mechanisms and interventions\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}